Tagged with EG

Switzerland Saad Harti, president of Legacy Healthcare, discusses the company’s origins, their unique focus on side-effect free botanical drugs for chronic conditions, and the importance of stakeholder education in this exciting but still immature field.   Most of our current emphasis is on alleviating side effects of cancer treatments, also called…

Austria Bernd Grabner, board member of Jacoby GM pharma, a leading Austrian wholesaler, provides an in-depth look into the historical merger of family owned Jacoby, GM pharma and Kӧgl Pharma as well as the moves being made to bolster a vertically integrated business model. Furthermore, he gives an overview of the…

Austria Barbara Fritsche-Surchat, general manager of Servier Austria, a leading innovative French company looking to bolster its global oncology presence, provides an in-depth analysis of the balancing act between pricing and market access in the Austrian healthcare system as well as how the company’s global oncology vision has influenced Austrian operations.…

Bulgaria Dr. Atanas Atanasov, country manager at Angelini Bulgaria, explains the affiliate’s growth to become a top ten player in the Bulgarian industry and highlights the leadership position of its portfolio in each category based on a long-term promotion strategy and value-based quality. Angelini started its internationalisation process ten years ago,…

Brazil In an exclusive interview, Minister of Health of Brazil Ricardo Barros provides insights into his main achievements since being appointed in May 2016 and his key priorities to further improve the management and delivery of Brazil’s public health system, while highlighting his expectations for pharmaceutical companies implanted in the country.…

Austria Rudolf Wessely, CEO and founder of Gynial, the Austrian leader in oral contraceptives, elaborates on the company’s incredibly fast market penetration since 2007 and explains his expertise in the contraceptive field. Furthermore, he discusses the importance of open communication with gynaecologists and Gynial’s unique product philosophy as well as the…

Canada Dr. Jeremy B. Desai, CEO & President of Apotex, the Canadian international generics powerhouse, discusses his mandate in 2014 to take the company global, the challenges and opportunities of increasing convergence between the generics, branded and biosimilars sectors globally, and the main growth engines for Apotex looking forward. Jeremy, you…

Austria Martin Tiani, CEO of Tiani Spirit, the global leader in Integrating the Healthcare Enterprise (IHE), discusses the importance of interoperability within electronic health information exchange (HIE) and the challenges e-health faces, especially for the company as they adapt to differing regulations in various nations. Furthermore, he highlights the grapevine initiative (grapevineworld.com) for…

ARM Annie Hubert, Senior Director, EU Section & Public Policy for the Alliance for Regenerative Medicine (ARM) describes some of the issues that companies in the advanced therapies field are facing in terms of market access and stakeholder education in Europe, as well as some of the key breakthroughs that European…

Bulgaria Aurélien Breton, general manager at Servier Bulgaria, explains how the affiliate has performed under his tenure and highlights the importance of combining the right portfolio with a top-notch team to successfully navigate the business environment in Bulgaria.  This is your second country management position after Slovenia, and you arrived in…

Canada Alok Kanti, president and CEO of Bayer Canada, draws upon his 27 years of international experience with Bayer to discuss the strategic significance of the Canadian affiliate to Bayer’s global operations, the challenges and opportunities he sees for industry-government collaboration, and the need for the country to promote a more…

Canada Michael Tremblay, president and CEO of Astellas Pharma Canada, Inc., draws upon his four decades of experience within the Canadian pharmaceutical industry to discuss his thoughts on the need for Canada to move away from a ‘silo-ed’ approach to healthcare spending, the value that Astellas has been bringing to patients…